rs11037909
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_207122.2(EXT2):c.1807-51T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.29 in 1,611,356 control chromosomes in the GnomAD database, including 72,112 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 5937 hom., cov: 32)
Exomes 𝑓: 0.29 ( 66175 hom. )
Consequence
EXT2
NM_207122.2 intron
NM_207122.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.957
Genes affected
EXT2 (HGNC:3513): (exostosin glycosyltransferase 2) This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 11-44234064-T-C is Benign according to our data. Variant chr11-44234064-T-C is described in ClinVar as [Benign]. Clinvar id is 1166104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-44234064-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXT2 | NM_207122.2 | c.1807-51T>C | intron_variant | ENST00000533608.7 | NP_997005.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXT2 | ENST00000533608.7 | c.1807-51T>C | intron_variant | 1 | NM_207122.2 | ENSP00000431173.2 |
Frequencies
GnomAD3 genomes AF: 0.260 AC: 39596AN: 152038Hom.: 5917 Cov.: 32
GnomAD3 genomes
AF:
AC:
39596
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.321 AC: 80056AN: 249572Hom.: 14574 AF XY: 0.317 AC XY: 42767AN XY: 135008
GnomAD3 exomes
AF:
AC:
80056
AN:
249572
Hom.:
AF XY:
AC XY:
42767
AN XY:
135008
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.293 AC: 427449AN: 1459200Hom.: 66175 Cov.: 33 AF XY: 0.294 AC XY: 213263AN XY: 725990
GnomAD4 exome
AF:
AC:
427449
AN:
1459200
Hom.:
Cov.:
33
AF XY:
AC XY:
213263
AN XY:
725990
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.261 AC: 39642AN: 152156Hom.: 5937 Cov.: 32 AF XY: 0.267 AC XY: 19900AN XY: 74398
GnomAD4 genome
AF:
AC:
39642
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
19900
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1497
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | This variant is associated with the following publications: (PMID: 17293876, 23052945) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Exostoses, multiple, type 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at